[an error occurred while processing this directive]

HEREDITAS ›› 2008, Vol. 30 ›› Issue (10): 1301-1306.doi: 10.3724/SP.J.1005.2008.01301

• 研究报告 • Previous Articles     Next Articles

A novel PAX6 mutation (c.1286delC) in the patients with hereditary congenital aniridia

SUN Da-Guang1, 2; YANG Ju-Hua2, 4; TONG Yi5; ZHAO Guang-Jian6; MA Xu1, 2, 3

  

  1. 1. Graduate School, Peking Union Medical College, Beijing 100730, China;
    2. Department of Genetics, National Research Institute for Family Planning, Beijing 100081, China;
    3. WHO Collaborative Center for Research in Human Reproduction, Beijing 100081, China;
    4. Biomedical Engineering Center of Fujian Medical University, Fuzhou 350004, China;
    5. Department of Ophthalmology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China;
    6. Fuzhou Southeast Eye Hospital, Fuzhou 350009, China

  • Received:2008-04-30 Revised:2008-07-03 Online:2008-10-10 Published:2008-10-10
  • Contact: MA Xu

Abstract:

Abstract: To study the molecular genetic mechanism of hereditary congenital aniridia, the entire coding exons (exon 4–13) of PAX6 gene and the flanking exon-intron junctions were amplified through PCR from the genomic DNA of all the two patients in a Chinese family with aniridia. PCR products were purified from agarose gel and sequenced. In both patients, a novel deletion mutation (c. 1286delC) in exon 11 was identified. Compared with the normal product of PAX6 gene, this mutation caused frame shifting, and generated a novel 55 amino acid peptide from codon 309. This deletion also resulted in a premature termination codon (PTC) and preterminated peptide synthesis. Meanwhile, this mutation was absent in all the unaffected family members and 50 normal control individuals through PCR-RFLP.